Acne Global Market Revenue Totals $2.8 Billion in 2009

Great news for you acne worriers out there!  The market for products related to acne and mouth pimples has been increasing at a steady pace.  What does that mean for the normal folk out there that suffer from pimples?  Simple!  With more money in the pool, there is much more opportunity for companies to get out there and innovate!


The current state of the world acne market is overcrowded with generics and alternative therapies, such as photodynamic therapy and UV/blue light therapy. According to GlobalData's research, "the global acne market was worth $2.8 billion in 2009. It is estimated to reach revenues of $3.02 billion by 2016 at a Compound Annual Growth Rate (CAGR) of 0.7%." A moderate increase in revenues describes the market outlook for the acne sector. Meanwhile, the acne therapeutics market is experiencing a shift towards products which are a combination of two or more effective acne treatments. "The currently marketed combination products such as Duac and Ziana are forecast to steadily increase their revenues," states GlobalData. Solodyn (minocycline hydrochloride) followed by Doryx (doxycycline), continue to represent the market leaders in the acne sector.

Here is the link to the original article.